UAB Medicine News
Grandmother’s Vision Struggle Motivates Young Woman to Make a Difference
As a young girl in Afghanistan, Fazila Aseem watched her grandmother struggle, because of vision loss, to independently complete daily tasks. Her grandmother was unable to see well enough to prepare simple meals for herself, and there was nothing Afghan doctors could do to restore her vision.
Many years later a simple cataract surgery significantly improved her grandmother’s vision and quality of life. Aseem wondered how many other older adults might be suffering from a curable condition because of treatment and care deficits.
Aseem’s curiosity sparked both a thirst for knowledge and a desire to improve treatment and care for older adults. This summer, through a fellowship from the American Federation in Aging Research, Aseem will work with researchers in the UAB Department of Ophthalmology to continue her interest in aging and vision research.
“Ophthalmology provides me with the ability to combine my interest in science with my humanitarian vision to make a positive impact in the lives of disadvantaged people, including older adults,” Aseem says. “In the future, I would like to be involved in both clinical practice as well as research so I can not only provide care but also help improve treatment options for vision impairments.”
Aseem, a medical student at Wake Forest University, will work with ophthalmology faculty members Christine A. Curcio, PhD, and Cynthia Owsley, PhD, and the Alabama Study on Early Age-Related Macular Degeneration (ALSTAR), funded by the National Institute on Aging of the National Institutes of Health. This study aims to uncover risk factors that make certain older adults more susceptible to age-related macular degeneration (AMD), a disease that causes central vision loss for millions of Americans.
“I want to continue my work with the ALSTAR project because it provides the unique opportunity to study the subcellular basis of clinical autofluorescence imaging and functional assays of transitioning from normal aging to AMD, under the supervision of two brilliant scientists in the field—Drs. Curcio and Owsley,” Aseem says. “I am also excited about the prospect of setting a potential diagnostic biomarker for the earliest emergence of AMD, so AMD patients are able to seek early care.”
Although treatment for AMD is available, it cannot begin until the later stages of the disease, when vision loss is extensive. Through the ALSTAR study and other lines of research, UAB Ophthalmology is focusing on understanding the earliest stages of AMD, hopeful that this work will lead to the next generation of treatments and, ideally, a way to prevent this devastating disease. “Autofluorescence is a superb way to monitor the retinal cells most affected by AMD. Fazila’s project will help us detect the very earliest stages of degeneration in ALSTAR study patients,” Curcio says. “Due to their participation in the ALSTAR study, these patients’ vision, health, and lifestyle are now well documented. The addition of autofluorescence imaging will lead us to biomarkers for the emergence of AMD.”
Produced by UAB Medicine Marketing Communications (learn more about our content).
New Year, New You: 6 Tips for Renewing Your Skin
Study shows some heart disease patients implanted with a VAD have better survival and are more likely to receive a heart transplant
UAB Medicine Helps Patients on Ventilators Get Their Voice Back
UAB Rated Among Best Hospitals for Maternity Care by U.S. News
Tips for Finding More Joy This Holiday Season